Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Urea-based glycogen phosphorylase a inhibitors newly developed at Aventis

Oct. 27, 2004

Novel MCH receptor antagonists prepared and tested at Schering-Plough

Oct. 27, 2004

Agents combining antimitotic, antiangiogenic and PDE4 activity claimed by Celgene

Oct. 27, 2004

New Eg5 kinesin inhibitors developed by AstraZeneca researchers

Oct. 27, 2004

Novel JNK inhibitors and their use reported by Eisai

Oct. 27, 2004

Merck researchers describe new anti-HIV vaccines

Oct. 27, 2004

ARS scientists develop new prostanoid agonists for female infertility, asthma, etc.

Oct. 26, 2004

New mGluR5 antagonists prepared and tested at Addex

Oct. 26, 2004

Novel IBAT inhibitors in early development at AstraZeneca

Oct. 26, 2004

New antibacterial oxazolidinones patented by AstraZeneca

Oct. 26, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...